Birdwatch Note
2023-03-16 23:07:04 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
NIAID/NIH does not develop bioweapons. NIH conducts civilian biodefense research with a focus on research and early development of medical countermeasures against terrorist threats from infectious diseases and radiation exposure. https://www.niaid.nih.gov/research/biodefense
Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1636125815938387970
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1636504383927078913
- noteId - 1636504383927078913
- participantId -
- noteAuthorParticipantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 Participant Details
- createdAtMillis - 1679008024567
- tweetId - 1636125815938387970
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- NIAID/NIH does not develop bioweapons. NIH conducts civilian biodefense research with a focus on research and early development of medical countermeasures against terrorist threats from infectious diseases and radiation exposure. https://www.niaid.nih.gov/research/biodefense
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-03-16 23:07:04 UTC (1679008024567) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-17 06:38:20 UTC (1679035100346) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-03-16 19:25:53 -0500 | Rating Details | |
2023-03-16 18:38:05 -0500 | Rating Details | |
2023-03-17 11:27:37 -0500 | Rating Details | |
2023-03-17 05:58:02 -0500 | Rating Details | |
2023-03-17 00:27:38 -0500 | Rating Details | |
2023-03-16 23:06:26 -0500 | Rating Details | |
2023-03-16 20:03:15 -0500 | Rating Details | |
2023-03-16 19:49:53 -0500 | Rating Details | |
2023-03-18 18:54:37 -0500 | Rating Details | |
2023-03-18 02:28:01 -0500 | Rating Details | |
2023-03-18 00:23:23 -0500 | Rating Details | |
2023-03-18 00:12:55 -0500 | Rating Details | |
2023-03-17 21:21:49 -0500 | Rating Details | |
2023-03-20 22:58:41 -0500 | Rating Details | |
2023-03-23 12:15:14 -0500 | Rating Details | |
2023-03-24 13:43:03 -0500 | Rating Details | |
2023-03-25 03:43:06 -0500 | Rating Details | |
2023-03-25 02:44:11 -0500 | Rating Details | |
2023-03-25 00:09:09 -0500 | Rating Details | |
2023-03-25 10:55:43 -0500 | Rating Details | |
2023-03-27 13:27:30 -0500 | Rating Details | |
2023-03-18 02:28:01 -0500 | Rating Details | |
2023-03-16 19:49:53 -0500 | Rating Details | |
2023-03-25 10:55:43 -0500 | Rating Details | |
2023-03-20 22:58:41 -0500 | Rating Details | |
2023-03-25 00:09:09 -0500 | Rating Details | |
2023-03-18 00:12:55 -0500 | Rating Details | |
2023-03-16 23:06:26 -0500 | Rating Details | |
2023-03-18 00:23:23 -0500 | Rating Details | |
2023-03-24 13:43:03 -0500 | Rating Details | |
2023-03-18 18:54:37 -0500 | Rating Details | |
2023-03-17 05:58:02 -0500 | Rating Details | |
2023-03-23 12:15:14 -0500 | Rating Details | |
2023-03-16 19:25:53 -0500 | Rating Details | |
2023-03-16 18:38:05 -0500 | Rating Details | |
2023-03-25 03:43:06 -0500 | Rating Details | |
2023-03-17 00:27:38 -0500 | Rating Details | |
2023-03-17 11:27:37 -0500 | Rating Details | |
2023-03-16 20:03:15 -0500 | Rating Details | |
2023-03-17 21:21:49 -0500 | Rating Details | |
2023-03-27 13:27:30 -0500 | Rating Details | |
2023-03-25 02:44:11 -0500 | Rating Details | |
2023-07-18 11:52:18 -0500 | Rating Details | |
2023-07-18 06:37:34 -0500 | Rating Details | |
2023-07-18 02:25:39 -0500 | Rating Details | |
2023-07-17 23:01:59 -0500 | Rating Details | |
2023-07-17 21:36:14 -0500 | Rating Details | |
2023-07-17 19:57:31 -0500 | Rating Details | |
2023-07-19 00:13:41 -0500 | Rating Details | |
2023-08-15 11:07:32 -0500 | Rating Details | |
2023-08-14 20:36:10 -0500 | Rating Details | |
2024-12-05 01:30:50 -0600 | Rating Details | |
2024-12-05 00:11:13 -0600 | Rating Details |